Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism

Biochemistry, Genetics and Molecular Biology

• Artificial Intelligence 100%
• Apolipoprotein 100%
• High-Density Lipoprotein 100%
• Blood Plasma 100%
• Deficiency 100%
• Wild Type 18%
• Knockout Mouse 13%
• Cholesteryl Ester 13%
• Microemulsion 13%
• Cholesterol Blood Level 9%
• Lipid 9%
• Wild Type Mouse 4%

Keyphrases

• Serum Opacity Factor 100%
• Apolipoprotein A-I (ApoA-I) 100%
• High-density Lipoprotein Cholesterol (HDL-C) 100%
• Stabilization Mechanism 100%
• Null Mice 15%
• Cholesteryl Ester 15%
• In(III) 10%
• Lipids 10%
• Plasma Cholesterol 10%
• Microemulsion 10%
• Guanidine Hydrochloride 10%
• Reconstituted High-density Lipoprotein (rHDL) 10%
• Wild Mice 5%
• Lipoproteins 5%
• Human Plasma 5%
• High-density Lipoprotein Function 5%
• Mouse Plasma 5%
• Mouse Serum 5%
• Chaotropic 5%
• Microemulsion Formation 5%
• Biochemical Perturbation 5%
• In Vivo Injection 5%
• In Vitro Produced 5%
• Perturbation Studies 5%